Hypnosis and self-care intervention for children with cancer and their parents

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This intervention aims to improve the quality of life for children with cancer and their parents through a group program that combines self-care techniques and hypnosis. The study focuses on addressing emotional distress, fatigue, and relational difficulties experienced by both children and their parents due to the challenges of cancer. By assessing the feasibility and efficacy of this approach, the researchers hope to enhance coping strategies and overall well-being. The intervention is designed for children aged 8 to 18 years and their parents, all of whom must speak French.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Children and their siblings:

  * To be 8 to 18 year-old
  * To suffer from cancer (all localisations, stage and treatments accepted) or to have a sibling who suffer from cancer
  * To speak french
* Parents:

  * To have a child who suffer from cancer
  * To speak french

Exclusion Criteria:

* /

Where it's running

• University Hospital of Liege
  Liège, Belgium Recruiting

Study contacts

• Study coordinator: Charlotte Grégoire
• Email: ch.gregoire@uliege.be
• Phone: 043662398

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• FaceSay: a computer program to help kids recognize facial expressions and improve social interactions

  A computer-based FaceSay program is tested to see if it helps survivors of pediatric brain tumors who have social difficulties see facial expressions better and relate more comfortably with peers.

  Recruiting Children's Hospital of Philadelphia · Philadelphia, Pennsylvania · NCT07923370

• Access to Innovative Cancer Treatments for Children and Young People in Belgium

  This observational study collects safety and effectiveness data on off‑label and compassionate cancer medicines used in kids and young adults up to age 25 in Belgium.

  Recruiting Universitaire Ziekenhuizen KU Leuven · Antwerp and 5 other locations · NCT07727694

• BCB-276 CAR T therapy for DIPG in children and young adults

  This study tests BCB-276, a patient's own CAR T cells against DIPG, after standard radiation, to see if it is safe and can help extend survival.

  Recruiting at 3 sites Phase 2 BrainChild Bio, Inc · Los Angeles, California and 5 other locations · NCT07680439

• CAYA cancer patients in LMICs: a forward-looking observation of care and outcomes

  This study follows children, teens, and young adults with cancer in low- and middle-income countries to see how routine care affects treatment, access, and outcomes over time.

  Recruiting Resonance, Inc. · Yerevan and 5 other locations · NCT07632014

• Virtual reality headsets to reduce anxiety and fear during intrathecal chemotherapy in children

  This project will try virtual reality headsets with children aged 4–10 who are receiving intrathecal chemotherapy to see if they reduce anxiety, fear, and changes in vital signs.

  Recruiting TC Erciyes University · Kayseri · NCT07537062

• Laser thermal therapy for young people with low-grade glioma

  This research will test whether laser interstitial thermal therapy (LITT) can stop or slow recurrent or progressive low-grade gliomas in children, adolescents, and young adults.

  Recruiting University of California, San Francisco · San Francisco, California · NCT07506239

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.